Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Invesco Large Cap Value ETF
PWV
$1.68B
| $743K | ﹤0.01% |
13,503
-2,505
| -16% | -$138K |
|
3002
GitLab
GTLB
$5.7B
| $741K | ﹤0.01% |
14,899
-15,688
| -51% | -$815K |
|
3003
Wabash National
WNC
$504M
| $739K | ﹤0.01% |
33,846
+4,552
| +16% | +$107K |
|
3004
iShares MSCI Saudi Arabia ETF
KSA
$622M
| $739K | ﹤0.01% |
18,195
+3,172
| +21% | +$134K |
|
3005
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$258M
| $739K | ﹤0.01% |
6,716
-857
| -11% | -$93K |
|
3006
Middlesex Water
MSEX
$1.04B
| $736K | ﹤0.01% |
14,082
+1,775
| +14% | +$92.2K |
|
3007
iShares MSCI Agriculture Producers ETF
VEGI
$152M
| $735K | ﹤0.01% |
20,552
+1,840
| +10% | +$68.3K |
|
3008
Rocket Pharmaceuticals
RCKT
$351M
| $734K | ﹤0.01% |
34,090
-251,053
| -88% | -$5.77M |
|
|
AVNS
3009
DELISTED
Avanos Medical
AVNS
| $734K | ﹤0.01% |
36,828
+3,328
| +10% | +$64.8K |
|
3010
AtriCure
ATRC
$2.04B
| $731K | ﹤0.01% |
32,116
+18,631
| +138% | +$430K |
|
3011
PUT
Teva Pharmaceuticals
TEVA
$41.2B
| $731K | ﹤0.01% |
45,000
-6,180,000
| -99% | -$95.2M |
|
3012
Imperial Oil
IMO
$62.3B
| $729K | ﹤0.01% |
10,694
+4,598
| +75% | +$317K |
|
3013
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
| $729K | ﹤0.01% |
7,696
+1,671
| +28% | +$158K |
|
3014
Protagonist Therapeutics
PTGX
$8.92B
| $728K | ﹤0.01% |
21,015
-187,626
| -90% | -$5.5M |
|
|
PFC
3015
DELISTED
Premier Financial Corp. Common Stock
PFC
| $727K | ﹤0.01% |
35,517
+4,462
| +14% | +$88.7K |
|
3016
Merchants Bancorp
MBIN
$2.55B
| $726K | ﹤0.01% |
17,904
+3,146
| +21% | +$129K |
|
3017
Arcus Biosciences
RCUS
$3.55B
| $726K | ﹤0.01% |
47,653
-268,474
| -85% | -$4.33M |
|
|
FFWM
3018
DELISTED
First Foundation Inc
FFWM
| $723K | ﹤0.01% |
110,341
-26,431
| -19% | -$162K |
|
3019
BioCryst Pharmaceuticals
BCRX
$2.35B
| $723K | ﹤0.01% |
116,945
-2,157,830
| -95% | -$11.9M |
|
3020
Encore Capital Group
ECPG
$2.02B
| $721K | ﹤0.01% |
17,289
+1,548
| +10% | +$66.8K |
|
3021
Shenandoah Telecom
SHEN
$631M
| $721K | ﹤0.01% |
44,173
+11,481
| +35% | +$185K |
|
3022
Sweetgreen
SG
$778M
| $720K | ﹤0.01% |
23,888
+642
| +3% | +$17.6K |
|
3023
State Street SPDR S&P Global Dividend ETF
WDIV
$280M
| $720K | ﹤0.01% |
12,180
+666
| +6% | +$39.9K |
|
3024
Oscar Health
OSCR
$9.42B
| $720K | ﹤0.01% |
45,486
+10,324
| +29% | +$190K |
|
3025
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
| $719K | ﹤0.01% |
5,900
-33,000
| -85% | -$4.07M |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.